Rheumatoid arthritis trials in Sweden
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Huddinge
- Age
- 18 years to 75 years
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - No phaseEnrolling by invitationNutrition in Rheumatoid Arthritis
- Where
- Gothenburg
- Age
- 18 years to 85 years
- People
- 120
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06831331 - Phase 4Taking peopleAnti-B-cell therapy in RA-ILD
- Where
- Goteborg, Linkoping, Malmo, Solna, Umea, Uppsala
- Age
- 18 years and over
- People
- 120
- Run by
- Vaestra Goetalandsregionen
See details and how to join2025-524872-51-00 · EU 2025-524872-51-00 - Phase 4Taking peopleMethMax trial
- Where
- Solna
- Age
- 18 years and over
- People
- 212 worldwide
- Run by
- Medical University of Vienna
See details and how to join2023-507714-27-00 · EU 2023-507714-27-00 - Phase 4Taking peopleUtvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad, öppen, non-inferiority, klinisk studie (OPRERA)
- Where
- Huddinge, Solna
- Age
- 18 years and over
- People
- 166
- Run by
- Karolinska University Hospital
See details and how to join2024-518775-54-00 · EU 2024-518775-54-00 - No phaseTaking peopleTreatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study
- Where
- Lund, Malmö, Örebro, Stockholm, Umeå
- Age
- 18 years and over
- People
- 128
- Run by
- taVNS AB
See details and how to joinNCT06779123 - Phase 4Taking peopleA multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.
- Where
- Falun, Göteborg, Huddinge, Linköping, Lund, Malmö, Mölndal, Örebro, Solna, Stockholm, Uppsala, Västerås
- Age
- 18 years and over
- People
- 705 worldwide
- Run by
- Karolinska Institutet
See details and how to joinNCT01491815 · EU 2024-516723-14-00 - Phase 4Taking peopleVaccination in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the immunogenicity of herpes-zoster vaccine (Shingrix) and protection against infection (HZ-REUMA)
- Where
- Lund
- Age
- 18 years and over
- People
- 1
- Run by
- Region Skane Skanes Universitetssjukhus
See details and how to join2023-506230-71-01 · EU 2023-506230-71-01 - No phaseEnrolling by invitationGOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, Sweden
- Where
- Gothenburg
- Age
- 18 years to 80 years
- People
- 5,100
- Run by
- Vastra Gotaland Region
See details and how to joinNCT04190758